9926.HK logo
HKSE · 9926.HKBiotechnologyUpdated Nov 10, 2026

Akeso, Inc. ROE

Profitability, historical returns, and peer comparisons.

The ROE as of November 2026 (TTM) for Akeso, Inc. (9926.HK) is -10.86%

According to Akeso, Inc.’s latest financial reports and current stock price. The company's current ROE is -10.86%. This represents a change of 83.01% compared to the average of -5.93% of the last 4 quarters.

Akeso, Inc. (9926.HK) Historical ROE (quarterly & annually)

How has 9926.HK ROE performed in the past?

The mean historical ROE of Akeso, Inc. over the last ten years is 645.04%. The current -10.86% ROE has changed -101.68% with respect to the historical average. Over the past ten years (40 quarters), 9926.HK's ROE was at its highest in in the December 2019 quarter at 2.40%. The ROE was at its lowest in in the June 2019 quarter at -24.00%.

Quarterly (TTM)
Annual

Average

645.04%

Median

-21.86%

Minimum

-44.33%

Maximum

5.28%

Akeso, Inc. (9926.HK) ROE by Quarter and Year

Discovering the peaks and valleys of Akeso, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 58.63%

Maximum Annual ROE = 5.28%

Minimum Annual Increase = -16731.25%

Minimum Annual ROE = -44.33%

Quarterly (TTM)
Annual
YearROEChange
2025-11.98%58.63%
2024-7.55%-117.47%
202343.23%-197.51%
2022-44.33%30.49%
2021-33.97%4.43%
2020-32.53%-100.62%
20195.28%-16731.25%

Akeso, Inc. (9926.HK) Average ROE

How has 9926.HK ROE performed in the past?

The current ROE of Akeso, Inc. (9926.HK) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

7.90%

5-year avg

-10.92%

10-year avg

645.04%

Akeso, Inc. (9926.HK) ROE vs. Peers

How is 9926.HK’s ROE compared to its peers?

Akeso, Inc.’s ROE is greater than Alphamab Oncology (-10.27%), less than InnoCare Pharma Limited (17.47%), less than GenFleet Therapeutics (Shanghai) Inc. (0%), less than Innovent Biologics, Inc. (6.06%), less than Antengene Corporation Limited (6.51%), greater than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (-32.32%), less than Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (2.43%), less than Shanghai Henlius Biotech, Inc. (20.41%), less than HBM Holdings Limited (21.50%), less than Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (13.13%),

Build a custom stock screener for Akeso, Inc. (9926.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Akeso, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Akeso, Inc. (9926.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Akeso, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Akeso, Inc.'s ROE?

How is the ROE calculated for Akeso, Inc. (9926.HK)?

What is the highest ROE for Akeso, Inc. (9926.HK)?

What is the 3-year average ROE for Akeso, Inc. (9926.HK)?

What is the 5-year average ROE for Akeso, Inc. (9926.HK)?

How does the current ROE for Akeso, Inc. (9926.HK) compare to its historical average?